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Campylobacter spp. are a major cause of bacterial gastroenteritis in people in the 
developed world, including New Zealand. Many sources and transmission routes 
exist, as these bacteria are common in animals and the environment. C. jejuni is 
most frequently associated with poultry whereas C. upsaliensis and C. helveticus 
with dogs and cats, respectively. Published data on Campylobacter in dogs and cats 
in New Zealand and on the pathogenic potential of C. upsaliensis and C. helveticus 
are very limited. This thesis investigated the prevalence of Campylobacter spp. in 
household dogs and cats in Manawatu region, New Zealand, and in raw meat pet 
food commercially available in Palmerston North, New Zealand. Five Campylobacter 
spp. were isolated and the prevalence rates were significantly influenced by the 
culture methods used. C. upsaliensis and C. helveticus were most frequently 
detected from dogs and cats, respectively and C. jejuni in pet food samples. An 
expanded panel of culture methods was used to screen working farm dogs and their 
home-kill raw meat diet in Manawatu. This study reported three Campylobacter spp. 
and Helicobacter winghamensis as being isolated from dogs for the first time. The 
culture methods were again shown to bias the prevalence estimates. The isolates of 
C. upsaliensis and C. helveticus from the household pets study and C. hyointestinalis 
from locally farmed deer were used in a study to investigate the analytical sensitivity 
in spiked human clinical faecal samples using the ProSpecTTM Campylobacter 
Microplate Assay test that was developed for detection of C. jejuni/coli. The results 
showed the ability of the test to detect all three species and showed the influence of 
bacterial dose, faecal consistency and of the individual faecal samples on the test 
results. Further studies investigated the pathogenic potential of C. upsaliensis and C. 
helveticus in comparison to C. jejuni using an insect model of disease, Galleria 
mellonella, and whole-genome analyses, respectively. The results of the survival 
analysis in the G. mellonella study indicated that C. upsaliensis and C. helveticus 
have pathogenic potential, but to a lesser extent than C. jejuni. Additionally, several 
variables of experimental design were shown to significantly influence estimates of 
hazard rates in survival analysis. Whole genome analyses also showed indications of 
the pathogenic potential of C. upsaliensis and C. helveticus relative to C. jejuni, and 
how it varies between and within species in association with the core and accessory 
genomes, functional gene content profiles, and documented and predicted 
pathogenic proteins. This thesis has furthered our understanding of the 
epidemiology, detection, and pathogenicity of Campylobacter spp. in dogs, cats and 
humans, and confirmed raw meat animal food as a potential source of 





Foremost I would like to thank my supervisors Dr Els Acke, Dr Anne Midwinter and 
Dr Patrick Biggs for their great support and guidance throughout the PhD and without 
whom this thesis would not had been written. I am very grateful to my collaborators 
Dr Wendi Roe, Mrs Lynn Rogers and, especially Dr Jonathan Marshall, for their help 
and teaching and to the mEpiLab and AgResearch staff. A special thank you to Prof 
Boyd Jones for support in many ways to keep me and the projects going. I am 
indebted to the funders of the research projects, and to the Massey University for 
financial support with the Doctoral Scholarship, the Joan Berry Fellowship, and the 
Travel grants awarded. 
 
I would like to specially thank my parents, mum Karmen and dad Boris, and all my 
family for all the love, and encouragement they have always given me. Diana and 
Steve, Anne and Hamish, Raewyn and John, and last but not least Ljubica and 
Jakša, have all stepped in as my “kiwi” and “PhD” mums and dads in this path too. 
Throughout this PhD I was surrounded by my many old and also new friends I made 
along the way that supported my endeavours and enriched my life with kindness, 
laughter and adventures. Huge thanks and hugs to Taž, RaŠtRkAnCi, Pat, Zoe, Anja, 
Kerrie, Lorelle, Paul, Kate and Fred, Lintonian and Cliftonian flatties, and office(s) 
roomies. Special thanks to my best friend Mirna Barbić to whom I promise a third 
road-trip of Aotearoa. 
 
 






• Zoonoses and Public Health (in press) ‘Isolation of Campylobacter spp. from 
client-owned dogs and cats, and retail raw meat pet food in the Manawatu, 
New Zealand’ K Bojanić, AC Midwinter, JC Marshall, LE Rogers, PJ Biggs, E 
Acke 
• Journal of Microbiological Methods (2016 Vol. 127, p236-241) ‘Analytical 
sensitivity of the ProSpecT® Campylobacter Microplate Assay for detection of 
C. upsaliensis, C. helveticus and C. hyointestinalis in spiked human clinical 
faecal samples’ K Bojanić, AC Midwinter, JC Marshall, LE Rogers, PJ Biggs, E 
Acke 
• CHRO conference 2015 (Rotorua, New Zealand) Research Abstract 
‘Pathogenicity of Campylobacter jejuni, C. upsaliensis and C. helveticus in the 
invertebrate disease model Galleria mellonella’ K Bojanić, AC Midwinter, PJ 
Biggs, JC Marshall, E Acke 
• CHRO conference 2015 (Rotorua, New Zealand) Poster Abstract ‘Diagnosis 
of campylobacteriosis in humans from the Manawatu, New Zealand’ K 
Bojanić, A Nohra, LE Rogers, J Delores-Main, JC Marshall, PJ Biggs, AC 
Midwinter, E Acke 
• ECVIM 2015 (Lisbon, Portugal) Poster abstract ‘Pathogenicity investigation of 
Campylobacter jejuni, C. upsaliensis and C. helveticus isolated from dogs and 
cats using Galleria mellonella larvae’ K Bojanić, AC Midwinter, PJ Biggs, J 
Marshall, E Acke  
6 
 
• ECVIM 2014 (Mainz, Germany) Poster abstract ‘Whole-genome analyses of 
Campylobacter upsaliensis and C. helveticus isolated from dogs and cats and 
in silico investigation of pathogenic potential’ K Bojanić, AC Midwinter, PJ 
Biggs, NP French, E Acke  
• NZVA conference 2014 (Hamilton, NZ) Invited Research lecture ‘Canine 
diarrhoea – Campylobacter conundrum’ K Bojanic, AC Midwinter, PJ Biggs, E 
Acke 
• CHRO conference 2013 (Aberdeen, UK) Research abstract ‘Comparison of 
six culture protocols for isolation of Campylobacter spp. from faecal and meat 
samples’ K Bojanic, AC Midwinter, L Rogers, PJ Biggs, E Acke 
• NZVA conference 2013 (Palmerston North, New Zealand) Research abstract 
‘Salmonella, E. coli and Campylobacter spp. in Working Farm Dogs in New 
Zealand and their Home-Kill Diets’ K Bojanic, AC Midwinter, PJ Biggs, J 
Benschop, N Cave, E Acke 
• WSAVA conference 2013 (Auckland, New Zealand) Winner of WSAVA 
Global One Health Congress Recognition Prize Research Abstract 
‘Campylobacter spp. in dogs and cats in New Zealand’ K Bojanic, AC 
Midwinter, E Kwan, PJ Biggs, E Acke 
• International Sheep and Beef Veterinary Congress 2013 (Rotorua, New 
Zealand) Research presentation ‘Salmonella, E. coli and Campylobacter spp. 
in Working Farm Dogs in New Zealand and their Home-Kill Diets’ K Bojanic, 




• Infectious Disease Research Centre Science Symposium 2012 
(Palmerston North, New Zealand) Research Poster ‘ProSpecT Campylobacter 
Microplate Assay: first results but second thoughts?’  K Bojanic, AC Midwinter, 
J Marshall, L Rogers, PJ Biggs, E Acke 
• ECVIM 2012 (Maastricht, The Netherlands) Research Abstract ‘ProSpecT 
Elisa in the diagnosis of Campylobacter spp. infections’ K Bojanic, AC 




Table of contents 
 
 
1. Introduction ....................................................................................................... 18 
1.1. General background ................................................................................... 18 
1.2. Thesis structure and format ....................................................................... 21 
2. Literature review ............................................................................................... 24 
2.1. Campylobacter ............................................................................................ 24 
2.1.1. Historical overview .................................................................................. 24 
2.1.2. Taxonomy and microbiology ................................................................... 26 
2.1.3. Sources of Campylobacter species ......................................................... 34 
2.1.4. Detection and identification methods ...................................................... 36 
2.1.5. Pathobiology ............................................................................................ 53 
2.1.6. Typing of Campylobacter species ........................................................... 61 
2.2. Epidemiology and public health ................................................................ 68 
2.2.1. Epidemiology in humans ......................................................................... 68 
2.2.2. Epidemiology in dogs and cats ................................................................ 77 
2.3. Research aims ............................................................................................. 90 
3. Isolation of Campylobacter spp. from client-owned dogs and cats, and 
retail raw meat pet food in the Manawatu, New Zealand ..................................... 94 
3.1. Impacts ......................................................................................................... 95 
3.2. Summary ...................................................................................................... 95 
3.3. Introduction ................................................................................................. 96 
3.4. Materials and methods ............................................................................... 98 
3.4.1. Study design ............................................................................................ 98 
3.4.2. Bacterial culture ....................................................................................... 98 
3.4.3. Isolate identification and genotyping ....................................................... 99 
3.4.4. Statistical analysis ................................................................................. 100 
3.5. Results ....................................................................................................... 101 
3.5.1. Dogs and cats ....................................................................................... 101 
3.5.2. Raw pet food products .......................................................................... 104 
3.5.3. Culture methods .................................................................................... 105 
9 
 
3.5.4. MLST of C. jejuni isolates ...................................................................... 105 
3.6. Discussion ................................................................................................. 108 
4. Isolation of emerging Campylobacter species in working farm dogs and 
their frozen home-kill raw meat diets .................................................................. 116 
4.1. Highlights ................................................................................................... 117 
4.2. Abstract ...................................................................................................... 117 
4.3. Introduction ............................................................................................... 118 
4.4. Materials and methods ............................................................................. 120 
4.4.1. Study design .......................................................................................... 120 
4.4.2. Campylobacter isolation ........................................................................ 121 
4.4.3. Campylobacter identification and typing ................................................ 123 
4.4.4. Statistical analysis ................................................................................. 124 
4.5. Results ....................................................................................................... 124 
4.6. Discussion ................................................................................................. 126 
5. Variation in the limit-of-detection of the ProSpecT Campylobacter 
Microplate enzyme immunoassay in stools spiked with emerging 
Campylobacter species ........................................................................................ 132 
5.1. Highlights ................................................................................................... 133 
5.2. Abstract ...................................................................................................... 133 
5.3. Introduction ............................................................................................... 134 
5.4. Materials and Methods .............................................................................. 136 
5.4.1. Isolates .................................................................................................. 136 
5.4.2. Patient samples ..................................................................................... 136 
5.4.3. EIA testing ............................................................................................. 137 
5.4.4. Quantification of bacterial loads ............................................................ 138 
5.4.5. Statistical analysis ................................................................................. 138 
5.5. Results ....................................................................................................... 139 
5.6. Discussion ................................................................................................. 144 
5.7. Conclusions ............................................................................................... 148 
6. Comparison of the pathogenic potential of emerging Campylobacter spp. 
using larvae of Galleria mellonella as an infection model ................................. 152 
6.1. Abstract ...................................................................................................... 153 
10 
 
6.2. Introduction ............................................................................................... 154 
6.3. Results ....................................................................................................... 155 
6.4. Discussion ................................................................................................. 166 
6.5. Concluding remarks .................................................................................. 176 
6.6. Materials and methods ............................................................................. 177 
6.6.1. Strains and cultures ............................................................................... 177 
6.6.2. Galleria mellonella assays ..................................................................... 180 
6.6.3. Campylobacter inocula .......................................................................... 181 
6.6.4. Histopathology ....................................................................................... 182 
6.6.5. Statistical analysis ................................................................................. 183 
7. Whole Genome Comparison of Campylobacter upsaliensis, C. helveticus 
and C. jejuni ........................................................................................................... 186 
7.1. Abstract ...................................................................................................... 187 
7.2. Introduction ............................................................................................... 188 
7.3. Materials and methods ............................................................................. 190 
7.3.1. Bacterial genomes sources ................................................................... 190 
7.3.2. Genomic DNA preparation .................................................................... 190 
7.3.3. Genome assembly, curation and annotation ......................................... 191 
7.3.4. Comparative genomics .......................................................................... 192 
7.3.5. Statistical analysis ................................................................................. 193 
7.4. Results and Discussion ............................................................................ 193 
7.5. Conclusions and limitations .................................................................... 228 
8. General discussion and future research ...................................................... 232 
9. References ....................................................................................................... 251 
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COG  Cluster of Orthologous Groups 
CoxPH Cox proportional hazard 
Ctrl  Control larvae 
DALY  Disability-adjusted life year 
DNA  Deoxyribonucleic acid 
EIA  antigen test / ProSpecT® Campylobacter Microplate Assay 
Fig.  Figure 
HL  High bacterial inoculum load 
ID  Identity number 
KM  Kaplan-Meier 
LL  Low bacterial inoculum load 
LOD  Limit of detection 
ML  Medium bacterial inoculum load 
MLST  Multilocus sequence typing 
NAAT  Nucleic acid-based test 
PBS  Phosphate buffered saline 
PBS-ctrl Phosphate buffered saline-inoculated larvae control 
PCR  Polymerase chain reaction 
qPCR  Quantitative polymerase chain reaction 
rMLST Ribosomal multilocus sequence typing 
RNA  Ribonucleic acid 
rRNA  Ribosomal ribonucleic acid 
SNP  Single nucleotide polymorphism 
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COG-specific functional groups 
 
A  RNA processing and modification  
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S  Function unknown  
T  Signal transduction mechanisms  
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